DISEASE SCANNER
Global Incurable Diseases Tracker
Hepatitis E
A liver disease caused by hepatitis E virus, transmitted primarily through contaminated water. Similar to hepatitis A in transmission and course. Most common in South Asia and East Asia. Genotypes 1 and 2 cause large waterborne outbreaks; genotypes 3 and 4 are zoonotic. High mortality in pregnant women (15-25%).
20.0M
111
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1HEV IgM antibody (acute infection)
- 2HEV IgG antibody (past infection)
- 3HEV RNA PCR
- 4Liver function tests
- 5Exclusion of other hepatitis viruses
Prognosis
Generally self-limited with recovery in weeks to months. Case fatality 0.5-4% (higher in pregnancy 15-25%, chronic liver disease). Chronic infection can develop in immunosuppressed. No carrier state in immunocompetent. Lifelong immunity after infection.
Prevention
- Safe drinking water
- Proper sanitation
- Hand washing
- Avoid undercooked pork/deer
- Vaccine (China only)
- Blood screening
Research Status
Vaccine (Hecolin) licensed in China but not widely available. Treatment is supportive. Ribavirin used in chronic HEV (immunosuppressed patients). Reduced immunosuppression in transplant patients. Safe water and sanitation are primary prevention. Pregnant women require special management.
Affected Countries
Sources
- https://www.cdc.gov/hepatitis/hev/index.htm
- https://www.who.int/news-room/fact-sheets/detail/hepatitis-e
- https://www.niddk.nih.gov/health-information/liver-disease/viral-hepatitis/hepatitis-e
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.